Russell Investments Group’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$174K Buy
18,415
+14,914
+426% +$142K ﹤0.01% 3234
2026
Q1
$32K Sell
3,501
-319
-8% -$2.67K ﹤0.01% 3473
2025
Q4
$28.4K Hold
3,820
﹤0.01% 3502
2025
Q3
$25.6K Sell
3,820
-3,216
-46% -$22.3K ﹤0.01% 3522
2025
Q2
$46.6K Buy
7,036
+832
+13% +$5.9K ﹤0.01% 2999
2025
Q1
$56.8K Buy
6,204
+6,178
+23,762% +$61.7K ﹤0.01% 2883
2024
Q4
$273 Buy
+26
New +$308 ﹤0.01% 3648
2022
Q1
Sell
-7,400
Closed -$107K 2762
2021
Q4
$107K Hold
7,400
﹤0.01% 2831
2021
Q3
$104K Buy
+7,400
New +$114K ﹤0.01% 2881

Other funds holding BVS

Russell Investments Group's BVS Position: Q2 2026 in Review

Russell Investments Group increased its Bioventus (BVS) stake by 426% in Q2 2026, buying an estimated $142K and bringing the position to 18,415 shares worth $174K. The position accounts for ﹤0.01% of the portfolio, ranked #3234.

Russell Investments Group first reported a position in BVS in Q3 2021 and has held it in 9 quarters since. 61 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Russell Investments Group held 18,415 shares of Bioventus worth $174K as of Q2 2026.
  • Russell Investments Group bought 14,914 Bioventus shares in Q2 2026, an estimated $142K.
  • Bioventus made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3234 holding.
  • Russell Investments Group first reported a position in Bioventus in Q3 2021 and has held it in 9 quarters since.
  • 61 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.